DealsInvestor consortium to take biopharma firm Syneos Health private for $7.1bnAccording to the terms of the deal, shareholders will receive $43 per share in cash.ByIris Dorbian10 May 2023•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs